Literature DB >> 29750595

Long-Term, Low-Frequency Cluster of a German-Imipenemase-1-Producing Enterobacter hormaechei ssp. steigerwaltii ST89 in a Tertiary Care Hospital in Germany.

Andreas F Wendel1, Sebastian Meyer1, René Deenen2, Karl Köhrer2, Susanne Kolbe-Busch1, Klaus Pfeffer1, Matthias Willmann3, Achim J Kaasch1, Colin R MacKenzie1.   

Abstract

Enterobacter cloacae complex is a common cause of hospital outbreaks. A retrospective and prospective molecular analysis of carbapenem-resistant clinical isolates in a tertiary care center demonstrated an outbreak of a German-imipenemase-1 (GIM-1) metallo-beta-lactamase-producing Enterobacter hormaechei ssp. steigerwaltii affecting 23 patients between 2009 and 2016. Thirty-three isolates were sequence type 89 by conventional multilocus sequence typing (MLST) and displayed a maximum difference of 49 out of 3,643 targets in the ad-hoc core-genome MLST (cgMLST) scheme (SeqSphere+ software; Ridom, Münster, Germany). The relatedness of all isolates was confirmed by further maximum-likelihood phylogeny. One clonal complex of highly related isolates (≤15 allele difference in cgMLST) contained 17 patients, but epidemiological data only suggested five transmission events. The blaGIM-1-gene was embedded in a class-1-integron (In770) and the Tn21-subgroup transposon Tn6216 (KC511628) on a 25-kb plasmid. Environmental screening detected one colonized sink trap in a service room. The outbreak was self-limited as no further blaGIM-1-positive E. hormaechei has been isolated since 2016. Routine molecular screening of carbapenem-nonsusceptible gram-negative isolates detected a long-term, low-frequency outbreak of a GIM-1-producing E. hormaechei ssp. steigerwaltii clone. This highlights the necessity of molecular surveillance.

Entities:  

Keywords:  Enterobacteriaceae; epidemiology; genotyping; metallo-beta-lactamases; molecular characterization

Mesh:

Substances:

Year:  2018        PMID: 29750595     DOI: 10.1089/mdr.2017.0433

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  6 in total

1.  Free online genome analyses reveal multiple strains in the beginning of a hospital outbreak of Enterobacter hormaechei carrying bla OXA-436 carbapenemase gene.

Authors:  Michael Kemp; Magnus G Jespersen; Annette Toft; Anette Holm
Journal:  J Infect Prev       Date:  2022-06-14

Review 2.  Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales.

Authors:  Rémy A Bonnin; Agnès B Jousset; Cécile Emeraud; Saoussen Oueslati; Laurent Dortet; Thierry Naas
Journal:  Front Med (Lausanne)       Date:  2021-01-20

3.  Surveillance of Enterobacter cloacae complex colonization and comparative analysis of different typing methods on a neonatal intensive care unit in Germany.

Authors:  Andreas F Wendel; Daniel Peter; Frauke Mattner; Michael Weiss; Marc Hoppenz; Sophia Wolf; Baris Bader; Silke Peter; Jan Liese
Journal:  Antimicrob Resist Infect Control       Date:  2022-04-01       Impact factor: 4.887

4.  Co-occurrence of dual carbapenemases KPC-2 and OXA-48 with the mobile colistin resistance gene mcr-9.1 in Enterobacter xiangfangensis.

Authors:  Yancheng Yao; Swapnil Doijad; Jane Falgenhauer; Judith Schmiedel; Can Imirzalioglu; Trinad Chakraborty
Journal:  Front Cell Infect Microbiol       Date:  2022-08-17       Impact factor: 6.073

5.  Molecular epidemiology of an extended multiple-species OXA-48 CPE outbreak in a hospital ward in Ireland, 2018-2019.

Authors:  Carina Brehony; Lisa Domegan; Margaret Foley; Margaret Fitzpatrick; Jacqueline P Cafferkey; Karina O'Connell; Binu Dinesh; Eleanor McNamara; Fionnuala Duffy; Fidelma Fitzpatrick; Karen Burns
Journal:  Antimicrob Steward Healthc Epidemiol       Date:  2021-12-08

6.  Carbapenem-Resistant Enterobacter hormaechei ST1103 with IMP-26 Carbapenemase and ESBL Gene bla SHV-178.

Authors:  Jian-Jun Gou; Na Liu; Li-Hua Guo; Hao Xu; Tao Lv; Xiao Yu; Yun-Bo Chen; Xiao-Bing Guo; Yu-Ting Rao; Bei-Wen Zheng
Journal:  Infect Drug Resist       Date:  2020-02-20       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.